These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30414740)

  • 1. Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignancies.
    Tortorella L; Casarin J; Mara KC; Weaver AL; Multinu F; Glaser GE; Cliby WA; Scambia G; Mariani A; Kumar A
    Gynecol Oncol; 2019 Jan; 152(1):151-156. PubMed ID: 30414740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major complications following exenteration in cases of pelvic malignancy: a 10-year experience.
    Wydra D; Emerich J; Sawicki S; Ciach K; Marciniak A
    World J Gastroenterol; 2006 Feb; 12(7):1115-9. PubMed ID: 16534855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors of surgical complications after pelvic exenteration for gynecological malignancies: a large single-institution experience.
    Tortorella L; Marco C; Loverro M; Carmine C; Persichetti E; Bizzarri N; Barbara C; Francesco S; Foschi N; Gallotta V; Avesani G; Chiantera V; Ercoli A; Fanfani F; Fagotti A; Mele MC; Restaino S; Gueli Alletti S; Scambia G; Vizzielli G
    J Gynecol Oncol; 2024 Jan; 35(1):e4. PubMed ID: 37743057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution.
    Jäger L; Nilsson PJ; Rådestad AF
    Int J Gynecol Cancer; 2013 May; 23(4):755-62. PubMed ID: 23407096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of postoperative complications and quality of life between patients undergoing continent versus non-continent urinary diversion after pelvic exenteration for gynecologic malignancies.
    Angeles MA; Mallet E; Rouanet P; Cabarrou B; Méeus P; Lambaudie E; Foucher F; Narducci F; Loaec C; Gouy S; Guyon F; Marchal F; Gladieff L; Martínez-Gómez C; Migliorelli F; Martinez A; Ferron G
    Int J Gynecol Cancer; 2020 Feb; 30(2):233-240. PubMed ID: 31796531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Predictive of 90-Day Morbidity, Readmission, and Costs in Patients Undergoing Pelvic Exenteration.
    Bogani G; Signorelli M; Ditto A; Martinelli F; Casarin J; Mosca L; Leone Roberti Maggiore U; Chiappa V; Lorusso D; Raspagliesi F
    Int J Gynecol Cancer; 2018 Jun; 28(5):975-982. PubMed ID: 29683876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical results of pelvic exenteration in the treatment of gynecologic cancer.
    Petruzziello A; Kondo W; Hatschback SB; Guerreiro JA; Filho FP; Vendrame C; Luz M; Ribeiro R
    World J Surg Oncol; 2014 Sep; 12():279. PubMed ID: 25200866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer.
    Jalloul RJ; Nick AM; Munsell MF; Westin SN; Ramirez PT; Frumovitz M; Soliman PT
    J Gynecol Oncol; 2018 Sep; 29(5):e68. PubMed ID: 30022632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pelvic exenteration for gynecologic malignancies: Postoperative complications and oncologic outcomes.
    Romeo A; Gonzalez MI; Jaunarena J; Zubieta ME; Favre G; Tejerizo JC
    Actas Urol Esp (Engl Ed); 2018 Mar; 42(2):121-125. PubMed ID: 28911880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of tumor size on outcomes following pelvic exenteration.
    Smith B; Jones EL; Kitano M; Gleisner AL; Lyell NJ; Cheng G; McCarter MD; Abdel-Misih S; Backes FJ
    Gynecol Oncol; 2017 Nov; 147(2):345-350. PubMed ID: 28822555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic exenterations for gynecological malignancies: a study of 36 cases.
    Kaur M; Joniau S; D'Hoore A; Van Calster B; Van Limbergen E; Leunen K; Penninckx F; Van Poppel H; Amant F; Vergote I
    Int J Gynecol Cancer; 2012 Jun; 22(5):889-96. PubMed ID: 22617477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvements in pelvic exenteration: factors responsible for reducing morbidity and mortality.
    Goldberg JM; Piver MS; Hempling RE; Aiduk C; Blumenson L; Recio FO
    Ann Surg Oncol; 1998; 5(5):399-406. PubMed ID: 9718168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic exenteration for gynecologic malignancies: The experience of a tertiary center from Greece.
    Haidopoulos D; Pergialiotis V; Aggelou K; Thomakos N; Alexakis N; Stamatakis E; Rodolakis A
    Surg Oncol; 2022 Mar; 40():101702. PubMed ID: 35065392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pelvic exenteration--our experience].
    Nedialkov K; Magunska N; Bechev B
    Akush Ginekol (Sofiia); 2015; 54(9):19-23. PubMed ID: 26863791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morbidity after pelvic exenteration for gynecological malignancies: a retrospective multicentric study of 230 patients.
    Chiantera V; Rossi M; De Iaco P; Koehler C; Marnitz S; Fagotti A; Fanfani F; Parazzini F; Schiavina R; Scambia G; Schneider A; Vercellino GF
    Int J Gynecol Cancer; 2014 Jan; 24(1):156-64. PubMed ID: 24362721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of continent urinary diversion after pelvic exenteration for gynecologic malignancies.
    Karsenty G; Moutardier V; Lelong B; Guiramand J; Houvenaeghel G; Delpero JR; Bladou F
    Gynecol Oncol; 2005 May; 97(2):524-8. PubMed ID: 15863155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization and perioperative outcome of minimally invasive pelvic exenteration in gynecologic malignancies: A national study in the United States.
    Matsuo K; Matsuzaki S; Mandelbaum RS; Kanao H; Chang EJ; Klar M; Roman LD; Wright JD
    Gynecol Oncol; 2021 Apr; 161(1):39-45. PubMed ID: 33402282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urological complications after cystectomy as part of pelvic exenteration are higher than that after cystectomy for primary bladder malignancy.
    Brown KG; Solomon MJ; Latif ER; Koh CE; Vasilaras A; Eisinger D; Sved P
    J Surg Oncol; 2017 Mar; 115(3):307-311. PubMed ID: 27859276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic pelvic exenteration for gynaecological malignancy: is there any advantage?
    Martínez A; Filleron T; Vitse L; Querleu D; Mery E; Balague G; Delannes M; Soulie M; Pomel C; Ferron G
    Gynecol Oncol; 2011 Mar; 120(3):374-9. PubMed ID: 21215437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical site infection impact of pelvic exenteration procedure.
    Moghadamyeghaneh Z; Hwang GS; Hanna MH; Carmichael JC; Mills S; Pigazzi A; Stamos MJ
    J Surg Oncol; 2015 Oct; 112(5):533-7. PubMed ID: 26310696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.